Clinical Trial

Crisugabalin in NMOSD Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Exploratory Trial

Name: Crisugabalin in NMOSD Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Exploratory Trial — clinical trial record (NCT07699770)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: TERMINATOR

Not Yet Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

This study is a multicenter, prospective, randomized, double-blind, placebo-controlled exploratory investigation conducted in China.

Trial Details

NCT Number	NCT07699770
Lead Sponsor	Tang-Du Hospital
Conditions	Neuromyelitis Optica Spectrum Disorders (NMOSD), Neuropathic Pain
Enrollment	110 participants
Start Date	2026-06-15
Primary Completion	2027-10-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-13